Swiss-made overnight ortho-K lenses that gently reshape the cornea during sleep — delivering clear daytime vision and proven myopia control for children and young adults.
i-Night uses precision reverse-geometry lenses worn overnight to gently reshape the anterior corneal surface. On removal each morning, the cornea retains its new shape — giving the patient clear, unaided vision throughout the day without glasses or contact lenses.
Beyond vision correction, i-Night is one of the most clinically validated non-pharmaceutical methods for slowing childhood myopia progression — reducing the stimulus for axial elongation over time.
Multiple peer-reviewed studies report 30–60% reduction in axial elongation rate compared to spectacle correction in children and young adults.
Corrects myopia up to −6.00D (case-dependent). Lower prescriptions achieve full-day correction from the first few nights of wear.
No permanent corneal change. If lens wear is discontinued, the cornea returns to its original shape within 48–72 hours. Safe for long-term use.
No spectacles or contact lenses during the day. Ideal for children in sports, swimming, or dusty environments where daytime lens wear is impractical.
Manufactured by Appenzeller Kontaktlinsen AG in Switzerland. CE marked under EU Medical Device Regulation. ISO 18369 compliant manufacturing.
Cosmos Enterprises provides fitting guidance, topography-based parameter selection support, and training for i-Night orthokeratology across India.
Orthokeratology (Ortho-K) is the use of specially designed rigid gas-permeable lenses worn overnight to temporarily reshape the corneal surface. Upon waking and removing the lenses, the cornea provides clear unaided vision throughout the day. The effect is reversible and requires nightly lens wear to maintain.
Yes. Multiple peer-reviewed studies report 30–60% reduction in myopia progression rate with orthokeratology compared to spectacle correction. The peripheral defocus created by the Ortho-K lens on the retina is believed to suppress the axial elongation signal that drives myopia progression.
i-Night can correct myopia up to approximately −6.00D, depending on the case. Patients with lower prescriptions (−1.00D to −4.00D) typically achieve the most complete and stable full-day unaided vision. Cases above −4.00D may require individual assessment by a Cosmos Enterprises clinical consultant.
Orthokeratology is considered safe for children when fitted by trained eye care professionals with appropriate follow-up. i-Night lenses are CE certified to European medical device standards. Key safety factors include correct lens fit via corneal topography, strict hygiene education, and regular clinical reviews every 3–6 months.
Contact Cosmos Enterprises to enquire about i-Night, request a trial set, or discuss a patient case.
